imatinib mesylate has been researched along with Chloroma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, XJ; Jia, JS; Jiang, H; Kong, J; Ma, R; Qin, YZ | 1 |
| Chaudhary, SC; Jain, N; Kumar, V; Mishra, S | 1 |
| Cross, NC; Fabarius, A; Gosenca, D; Haferlach, C; Hochhaus, A; Hofmann, WK; Metzgeroth, G; Reiter, A; Schwaab, J | 1 |
| Barwad, A; Pubbaraju, SV; Srinivas, U | 1 |
| Kittai, A; Tabbara, I; Yu, EM | 1 |
| Derwich, K; Januszkiewicz-Lewandowska, D; Pieczonka, A; Samborska, M; Skalska-Sadowska, J; Wachowiak, J | 1 |
| Jotterand, M; Muehlematter, D; Rausch, T; Spertini, O; Stalder, M; Védy, D | 1 |
| Bittencourt, H; Castro, LC; Clementino, NC; Freitas, IF; Macedo, AV; Mendes, CU; Oliveira, FB; Rego, EM; Resende, C; Vieira, AK | 1 |
| Chang, H; Chuang, WY; Tang, TC | 1 |
| Frazão Rosa, Fde O; Maria Morselli, F; Ommati, LV; Rodrigues Oliveira, JS; Rosário Cavalheiro, Rde C; Vicari, P | 1 |
| Altintas, A; Ayyildiz, O; Cil, T; Kaplan, MA; Kilinc, I | 1 |
| Ge, W; Hu, J; Song, E; Xie, Z; Zhang, F; Zhu, F | 1 |
| Ahmed, MS; Cheng, YC; Davis, NB; King, DM; Kroft, SH | 1 |
1 review(s) available for imatinib mesylate and Chloroma
| Article | Year |
|---|---|
Intraoral granulocytic sarcoma presenting as multiple maxillary and mandibular masses: a case report and literature review.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Jaw Neoplasms; Piperazines; Pyrimidines; Remission Induction; Sarcoma, Myeloid | 2007 |
13 other study(ies) available for imatinib mesylate and Chloroma
| Article | Year |
|---|---|
Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.
Topics: Adult; Humans; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Sarcoma, Myeloid | 2019 |
Multiple skin chloromas: a rare presentation of chronic myelogenous leukaemia in chronic stable phase.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Sarcoma, Myeloid; Skin Neoplasms | 2013 |
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.
Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Eosinophilia; Follow-Up Studies; Gene Rearrangement; Humans; Imatinib Mesylate; Leukemia, Myeloid; Lymphoma, T-Cell; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prognosis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Sarcoma, Myeloid; Survival Rate | 2013 |
Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.
Topics: Antineoplastic Agents; Benzamides; Gene Rearrangement; Humans; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma, Myeloid; Treatment Outcome; Young Adult | 2014 |
Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remission.
Topics: Adult; Antineoplastic Agents; Back Pain; Benzamides; Cytogenetic Analysis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Remission Induction; Sarcoma, Myeloid; Spine | 2014 |
Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.
Topics: Antineoplastic Agents; Benzamides; Bone Marrow Transplantation; Child; Combined Modality Therapy; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mutation; Nuclear Proteins; Nucleophosmin; Philadelphia Chromosome; Piperazines; Pyrimidines; Remission Induction; Sarcoma, Myeloid; Transplantation, Homologous | 2015 |
Myeloid Sarcoma as the First Sign of Progression of Chronic Myeloid Leukemia in Medullary Chronic Phase: Experience from a Tertiary Cancer Centre in Southern India.
Topics: Adult; Disease Progression; Female; Humans; Imatinib Mesylate; India; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Sarcoma, Myeloid | 2017 |
Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib.
Topics: Antineoplastic Agents; Benzamides; Eosinophilia; Humans; Imatinib Mesylate; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Pyrimidines; Remission Induction; Sarcoma, Myeloid | 2010 |
Granulocytic sarcoma of the stomach: relapse after hematopoietic stem-cell transplantation for chronic myeloid leukemia.
Topics: Adolescent; Antineoplastic Agents; Benzamides; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Second Primary; Piperazines; Pyrimidines; Sarcoma, Myeloid; Stomach Neoplasms; Transplantation, Homologous | 2010 |
Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
Topics: Adult; Benzamides; Humans; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma, Myeloid | 2012 |
Granulocytic sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy.
Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Fatal Outcome; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Second Primary; Piperazines; Pyrimidines; Radiography; Sarcoma, Myeloid | 2006 |
Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Blood-Brain Barrier; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Methotrexate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma, Myeloid; Treatment Outcome | 2007 |
Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
Topics: Benzamides; Chromosome Aberrations; Cytogenetic Analysis; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Myeloid | 2008 |